|Home | About | Journals | Submit | Contact Us | Français|
More than one third of patients with subarachnoid hemorrhage (SAH) develop clinically significant vasospasm, as a leading morbidity and mortality factor for these patients. It is widely accepted that a) Degradation products of blood are the causative factors of vasospasm b) The amount of subarachnoid blood seen on admission CT is correlated to the risk of vasospasm c) Reducing the subarachnoid clot burden at the time of surgery reduces the risk of vasospasm. But there is no existing method to clear the blood from subarachnoid spaces satisfactorily. We have evaluated safety and feasibility of fluid exchange catheter system in SAH, to achieve this goal. We were successful in clearing cisternal blood in three patients with aneurysmal rupture with fluid exchange catheter system. Baseline CT scan of brain was performed immediately after the surgery and then at the end of irrigation. The amount of subarachnoid blood was evaluated. This innovative, fluid exchange catheter system infuses and aspirates micro volumes of drug solution in a cyclic mode, ensuring isobaric exchange of fluids. The result is good clearance of blood in subarachnoid spaces were seen in all the patients. Also, significant improvement in neurological deficits secondary to vasospasm was seen. We conclude that the fluid exchange catheter system is safe and adoptable in neurosurgical practice.
The outcome of subarachnoid hemorrhage (SAH) is often complicated by the occurrence of vasospasm. Angiographic vasospasm is seen in 30-70% of patients with aneurysmal SAH.[1,2] Of these symptoms of cerebral ischemia with high risk of debilitating stroke and mortality, clinically significant spasms can occur in 20-30% of patients. Many theories have been proposed and several treatment regimens have been tried to treat vasospasm. Till date, there is no satisfactory method to adequately treat vasospasm. Among the several variables, the amount of subarachnoid blood has significant correlation to the development of spasm.[4,5] It is also well known that clearing of blood from the cisterns during surgery helps in reducing the incidence and severity of vasospasm. Technically, it may be difficult and invasive to clear all the blood satisfactorily.
We have used a fluid exchange catheter system (FLUX) which infuses and aspirates micro volumes of fluid and drug solution in a cyclic mode. This is done in an isobaric exchange of fluids and can clear cisternal blood after aneurysm surgery.
With scientific and ethical approval, as well as with written informed consent from the patient and/or legally acceptable representative, FLUX catheter was placed in the subarachnoid space after aneurysm clipping in three patients with severe SAH (Fisher grade 3). We used an average of five liters of Ringer's Lactate with papavarine at a concentration of 8×10-5 M, for 72 hours, starting immediately after surgery. CT scan performed at the end of this period showed no residual blood in the subarachnoid spaces in all the three patients. Patient 1 did not develop any vasospasm and was discharged with intact neurological status [Figure [Figure1a1a and andb].b]. Patients’ 2 and 3, who had already severe vasospasm on admission, improved significantly, clinically, over four to six weeks, and was also discharged with no neurological deficit [Figure [Figure2a2a and andbb].
More than one third of patients with subarachnoid hemorrhage (SAH) develop clinically significant vasospasm, as a leading morbidity and mortality factor for these patients. It is widely accepted that a) Degradation products of blood are the causative factors of vasospasm[7,8] b) The amount of subarachnoid blood seen on admission CT is correlated to the risk of vasospasm c) Reducing the subarachnoid clot burden at the time of surgery reduces the risk of vasospasm.
Clearing the subarachnoid blood from cisterns following aneurysm rupture remains a technical challenge. Neurosurgeons adopted variety of irrigation methods and drains intra- and post-operative period, respectively. Risk of increasing intracranial pressure (ICP) in adequate clearance and infection were the usual risks. We have over come these problems with FLUX double lumen catheter which infuses and simultaneously aspirates fluid. Since it is a volume regulated and pressure controlled system through a built-in programmed soft ware, there in risk of increasing ICP. In our experience, 72 hours are more than sufficient, and hence, risk of infection is negligible. We have not only found it effective, but also have found the advantage of infusing a drug in micro quantities and deriving the best therapeutic benefit in addition. In our preliminary experience, there were no notable complications, safe and user friendly. The clinical benefits associated are very much encouraging to make this method as part of SAH treatment protocol.
The FLUX fluid exchange system is an effective method for clearing blood in the subarachnoid spaces with the infusion of drug, leading to either prevention or clearance of vasospasm with clinical benefit. This is a safe and adoptable method in neurosurgical practice.
Source of Support: Nil
Conflict of Interest: None declared.